About EUCODIS
EUCODIS is a Healthcare company based in Vienna (Austria) founded in 2007, and was acquired by Biosynth in August 2022. Drug research, enzyme identification, biocatalysis, and formulation services are provided. Its chief executive, as recorded, is Jan Modregger. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides.
Company details
Critical raw materials and services supplier for pharma, vaccines, and diagnostics. It supplies a wide array of chemical and biochemical products, focusing on small molecules, peptides, and key biological raw materials. The company offers comprehensive services supporting life science research and development, including custom synthesis and manufacturing. Its expertise spans complex chemistry, biocatalysis, bioconjugates, peptide discovery and production, and biologics for diagnostics. Manufacturing capabilities range from milligram to multi-ton scales, adhering to ISO 9001 and GMP standards. The company serves pharmaceutical, life science, and diagnostic sectors, as well as food, agrochemical, and cosmetic industries.
- Headquarters Vienna, Austria
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website eucodis-enzymes.com
- Social LinkedIn YouTube
- Acquired by Biosynth (Aug 2022)
Apps and channels of EUCODIS
its YouTube channel Biosynth has 97 subscribers and 30 videos.
Videos from EUCODIS
The most watched videos on EUCODIS's YouTube channel, Biosynth (97 subscribers). Click a video to play it here.
More on Biosynth.
Investors in EUCODIS
EUCODIS has secured backing from 1 investor. Prominent investors backing the company include Biosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics. | 1966 | biosynth.com | Thal, Switzerland |
Investor details for EUCODIS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EUCODIS
1 people are tracked at EUCODIS (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jan Modregger | CEO | Leadership |
Complete people profiles for EUCODIS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EUCODIS
2 dated milestones of EUCODIS across 15 years, from founding to its latest funding, stage changes and deals.
- Founded EUCODIS is founded.
- Exit Acquired by Biosynth.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EUCODIS
EUCODIS was founded in 2007.
EUCODIS is headquartered in Vienna, Austria.
Jan Modregger is the CEO of EUCODIS, as recorded in our data.
Critical raw materials and services supplier for pharma, vaccines, and diagnostics. It supplies a wide array of chemical and biochemical products, focusing on small molecules, peptides, and key biological raw materials. The company offers comprehensive services supporting life science research and development, including custom synthesis and manufacturing. Its expertise spans complex chemistry, biocatalysis, bioconjugates, peptide discovery and production, and biologics for diagnostics. Manufacturing capabilities range from milligram to multi-ton scales, adhering to ISO 9001 and GMP standards. The company serves pharmaceutical, life science, and diagnostic sectors, as well as food, agrochemical, and cosmetic industries.
EUCODIS has 1 investor. Key investors include Biosynth.
Yes. EUCODIS was acquired by Biosynth in August 2022.